Form 4: Quest Diagnostics CFO Sells Shares for Tax Obligations

Quest Diagnostics Executive Vice President and CFO Sam Samad disposed of 850 shares of common stock to cover tax liabilities from restricted stock unit vesting.

Summary

• Sam Samad, Executive Vice President and Chief Financial Officer of Quest Diagnostics Inc. (DGX), reported a transaction on July 16, 2025.
• The transaction involved the disposition of 850 shares of Quest Diagnostics common stock.
• The shares were sold at a price of $169.01 per share.
• The sale was specifically conducted to satisfy tax obligations that arose from the vesting of a previous grant of restricted stock units.
• Following this transaction, Sam Samad beneficially owns 25,601 shares of common stock directly.

Sentiment

Score: 5

Explanation: The transaction is neutral as it is a routine sale to cover tax obligations from RSU vesting, not indicative of a change in investment sentiment or company performance.

Future Outlook

NA

Industry Context

This transaction is a routine insider filing related to executive compensation and tax obligations, common across all industries, including the diagnostics and healthcare services sector where Quest Diagnostics operates. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The sale of 850 shares by a CFO is a minor transaction and is unlikely to have a material impact on the company's stock price or shareholder value.
• Employees: No direct impact on employees is indicated.
• Customers: No direct impact on customers is indicated.
• Suppliers: No direct impact on suppliers is indicated.
• Creditors: No direct impact on creditors is indicated.

Key Dates

Keywords

Quest Diagnostics, DGX, SEC Form 4, Insider Trading, Stock Sale, CFO, Restricted Stock Units, Tax Obligations